Ramsay share price up 26% YTD: is it a buy?

The Ramsay Health Care Limited (ASX: RHC) share price is up 26% YTD. Is it a buy today?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Ramsay Health Care Limited (ASX: RHC) shareholders have been rewarded for holding the stock in 2019 very handsomely so far. Ramsay shares started the year around the $57.76 mark, but as of the time of writing today, Ramsay shares are trading places for $72.84 a share, a gain of over 26% for the year so far. So what is behind Ramsay's surge in price? And are Ramsay shares a buy today?

A Ramsay refresher

Ramsay Health Care is Australia's largest private hospital owner-operator. Ramsay boasts over 220 hospitals across Australia as well as in the United Kingdom, France, Indonesia, and Malaysia. The company has concentrated on building a brand around low-cost, high-quality care, which they have executed on successfully.

As Ramsay has grown, its ability to use its scale to force down costs has grown with it. The company is able to effectively negotiate with providers of private health insurance like Medibank Private Ltd (ASX: MPL), as well as suppliers of medical equipment and medicines, which has helped Ramsay achieve a significant cost-advantage as well as a high return on capital of its investments.

What is behind this price surge?

So as you can see, there is a lot to like about Ramsay as a business. The company was facing some structural challenges earlier this year regarding some of the company's acquisitions, but investors are now looking past these as Ramsay expects that core earnings-per-share growth will resume at historical levels from next year. Further, with the surprise re-election of the Liberal/National parties in May, the threat of capped private health insurance price rises that the Labor Party had proposed has now been priced out of Ramsay's shares.

Ramsay has a very impressive record of increasing its dividend every year since 2000. In today's market environment, quality dividend-yielding shares are being priced at a premium (yesterday's interest rate cut will do nothing to slow this trend) and so this had undoubtedly lead to further appreciation in the Ramsay share price.

Is Ramsay a buy today?

The appreciation in Ramsay's stock price over the year so far now leaves the company with a price-to-earnings ratio of nearly 40. This is a touch high for my liking, because although Ramsay is a quality company with many tailwinds behind it as well as a growing dividend, it does not have growth rates to justify this pricing optimism (in my humble opinion).

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Three Archer Materials scientists wearing white coats and blue gloves dance together in their lab after making a discovery
Healthcare Shares

Which ASX 200 healthcare share with AI upside just hit a new 52-week high?

And top broker Goldman Sachs says the share price can go even higher.

Read more »

Emotional euphoric young woman giving high five to male partner, celebrating family achievement, getting bank loan approval, or financial or investing success.
Share Gainers

If you invested $8,000 in Mesoblast shares at the beginning of 2024, guess how much you'd have now!

Mesoblast shares have been soaring higher over the past six weeks. But why?

Read more »

Lab worker puts hands in the air and dances around
Healthcare Shares

Up 200% in 6 months, guess which ASX All Ords stock just hit another all-time high

This All Ords stock has made its investors very rich in recent months...

Read more »

Man with a sleep apnoea mask on whilst sleeping.
Healthcare Shares

Is the Resmed share price a buy before the ex-dividend day?

Is this stock a healthy opportunity?

Read more »

Woman flexes muscles after donating blood.
Healthcare Shares

Top broker predicts 14% upside for CSL share price

Brokers are giving CSL shares a thumbs up right now.

Read more »

Three guys in shirts and ties give the thumbs down.
Healthcare Shares

Why is the Mesoblast share price taking a dive on Tuesday?

This high-flying share is under pressure today. But why?

Read more »

Group of Imugene scientists cheering in the lab after the company received another patent for HER-Vaxx
Healthcare Shares

3 ASX healthcare shares outperforming on quarterly updates

These stocks are charging ahead on an otherwise lacklustre trading day.

Read more »

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Healthcare Shares

Why is the ResMed share price surging again and up 14% in two sessions?

A recent update has gone down exceptionally well with investors.

Read more »